Companies: 48,686 Total Market Cap: 127339687136261.19

Henry Schein

NASDAQ: HSIC
Healthcare Medical Distribution
Rank #2103
Market Cap 8.39 B
Volume 2.11 M
Price 68.89
Change (%) 3.49%
Country or region United States United States

Henry Schein's latest marketcap:

8.39 B

As of May 9, 2025, Henry Schein's market capitalization has reached $8.39 B. According to our data, Henry Schein is the 2103th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 8.39 B
Revenue (ttm) 12.67 B
Net Income (ttm) 407 M
Shares Out 121.72 M
EPS (ttm) 3.21
Forward PE 13.90
Ex-Dividend Date n/a
Earnings Date May 5, 2025
Market Cap Chart
Data Updated: May 9, 2025

Henry Schein's yearly market capitalization.

Henry Schein has seen its market value grow from $1.78 B to $8.39 B since 1998, representing a total increase of 370.90% and an annual compound growth rate (CAGR) of 6.06%.
Date Market Cap Change (%)
May 9, 2025 $8.39 B -7.23%
December 31, 2024 $8.63 B -12.3%
December 29, 2023 $9.84 B -9.13%
December 30, 2022 $10.83 B 0.7%
December 31, 2021 $10.75 B 12.63%
December 31, 2020 $9.55 B -2.5%
December 31, 2019 $9.79 B -18.2%
December 31, 2018 $11.97 B 9.13%
December 29, 2017 $10.97 B -10.18%
December 30, 2016 $12.21 B -6.91%
December 31, 2015 $13.12 B 14.41%
December 31, 2014 $11.47 B 16.88%
December 31, 2013 $9.81 B 38.62%
December 31, 2012 $7.08 B 21.55%
December 30, 2011 $5.82 B 2.78%
December 31, 2010 $5.66 B 19.02%
December 31, 2009 $4.76 B 45.17%
December 31, 2008 $3.28 B -40.37%
December 31, 2007 $5.50 B 26.72%
December 29, 2006 $4.34 B 14.05%
December 30, 2005 $3.80 B 26.25%
December 31, 2004 $3.01 B 2.15%
December 31, 2003 $2.95 B 48.97%
December 31, 2002 $1.98 B 25.28%
December 31, 2001 $1.58 B 9.84%
December 29, 2000 $1.44 B 165.58%
December 31, 1999 $541.80 M -69.57%
December 31, 1998 $1.78 B

Company Profile

About Henry Schein, Inc.

Henry Schein, Inc. is a global provider of health care products and services, catering primarily to office-based dental and medical practitioners, as well as alternate care sites. Founded in 1932 and headquartered in Melville, New York, the company operates through three key segments:

  • Global Distribution and Value-Added Services
  • Global Specialty Products
  • Global Technology

Products and Services

The company offers a comprehensive range of solutions, including:

  • Dental Products: Infection-control supplies, handpieces, preventatives, impression materials, composites, anesthetics, dental implants, and PPE products.
  • Dental Equipment: Chairs, delivery units, lights, digital labs, X-ray equipment, and high-tech restoration tools, along with repair services.
  • Pharmaceuticals & Medical Supplies: Branded and generic drugs, vaccines, surgical products, diagnostic tests, and vitamins.
  • Financial & Consulting Services: Nonrecourse financing, practitioner education, and consulting.
  • Specialty Products: Dental implants, biomaterials, endodontic, orthodontic, and orthopedic solutions.
  • Technology Solutions: Practice management software and e-services for health care providers.

Customer Base

Henry Schein serves a diverse clientele, including:

  • Dental practices and laboratories
  • Physician practices and ambulatory surgery centers
  • Government and institutional health care clinics
  • Other alternate care facilities
Frequently Asked Questions

As of May 9, 2025, Henry Schein (including the parent company, if applicable) has an estimated market capitalization of $8.39 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Henry Schein global market capitalization ranking is approximately 2103 as of May 9, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1932
IPO Date November 3, 1995
Employees 25,000
CEO Stanley Bergman
Sector Healthcare
Industry Medical Distribution
Address 135 Duryea Road
Melville, New York 11747
United States